『Effective corticosteroid agent ‘Spolon Tablet’ launched』

 

 

KyungDong Pharm Co., Ltd. releases the adrenocorticosteroid drug ‘Spolon Tablet (methylprednisolone 4mg)’ on October 1, 2014.

‘Spolon tablets’ contain methylprednisolone, which is a methyl group introduced into prednisolone, and are a product that reduces adverse reactions such as edema and increased blood pressure due to sodium retention compared to prednisolone preparations.

It can be used for a very wide range of indications, including rheumatic disorders, collagen diseases, skin diseases, allergic diseases, and ophthalmic diseases, and is expected to be helpful in treating various diseases in most departments in the future.

 

 

 

 

 

♤ Product Information ♤

Product Name

Spollon Jeong

Ingredient content

Methylprednisolone 4 mg

Indications

Endocrine disorders, rheumatic disorders, collagen diseases, skin diseases,

Allergic diseases, eye diseases, gastrointestinal diseases, respiratory diseases, blood diseases, malignant neoplastic diseases, edematous diseases, nervous system diseases, etc.

Dosage and usage

Varies from 4-48mg per day. (Depends on symptoms of specific disease)

Reimbursement Prices

98 won/tablet

Reimbursement Code

648103410

Packaging unit

30 tablets, 200 tablets

 

※ Please refer to the product manual for other details such as precautions for use.